跳至主要内容
CAS 0 条记录

CAS 106685-40-9

CAS 106685-40-9 与法规 1223/2009 附件 II–VI 中的 0 条欧盟附件记录相匹配。

CAS 106685-40-9 的记录

0 共
未找到此 CAS 编号的记录。

化学身份与性质

CAS 106685-40-9 的 PubChem 二维化学结构
CAS 106685-40-9PubChem CID 60164

Adapalene

Adapalene is a naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether. It has a role as a non-steroidal anti-inflammatory drug, a dermatologic drug and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is a monocarboxylic acid, a naphthoic acid and a member of adamantanes. It is functionally related to a CD437. — ChEBI

IUPAC 名称
6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid
分子式
C28H28O3
分子量
412.5 g/mol
精确质量
412.20384475 Da
XLogP3
7.7
拓扑极性表面积
46.5 Ų
氢键供体
1
氢键受体
3
共价单元
1
已定义的立体中心
0

又称

DifferinAdaferinAdapalenoCD-271AdapalenumDifferineCD 2716-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid
另有 16 个已报告名称
CD2716-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid6-(4-Methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid1L4806J2QF6-[3-(adamantan-1-yl)-4-methoxyphenyl]naphthalene-2-carboxylic acidIDP-126 Component AdapaleneCHEBI:31174CABTREO COMPONENT ADAPALENE2-Naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo(3.3.1.1(sup 3,7))dec-1-ylphenyl)-AdaplaeneEffaclarAdapalene Gel6-(3-(adamantan-1-yl)-4-methoxyphenyl)naphthalene-2-carboxylic acidProactiv MD Kit6-(4-Methoxy-3-tricyclo(3.3.1.13,7)dec-1-ylphenyl)-2-naphthalenecarboxylic AcidCurist Acne Relief
外部数据库标识符

来自其他科学数据库的证据

EMBL-EBI ChEBI
标识符精确匹配CHEBI:31174

adapalene

A naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether.

配方
C28H28O3
平均质量
412.529 g/mol
单同位素质量
412.20384 Da
形式电荷
0
  • naphthoic acid — is a (CHEBI:25483)
  • monocarboxylic acid — is a (CHEBI:25384)
  • adamantanes — is a (CHEBI:51339)
  • dermatologic drug — has role (CHEBI:50177)
  • non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
  • EC 2.7.11.22 (cyclin-dependent kinase) inhibitor — has role (CHEBI:82665)
  • CD437 — has functional parent (CHEBI:88334)
  • dermatologic drug — has role (CHEBI:50177)
  • non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
  • EC 2.7.11.22 (cyclin-dependent kinase) inhibitor — has role (CHEBI:82665)
  • naphthoic acid — is a (CHEBI:25483)
  • monocarboxylic acid — is a (CHEBI:25384)
  • adamantanes — is a (CHEBI:51339)
其他整理的名称
6-(3-adamantan-1-yl-4-methoxyphenyl)naphthalene-2-carboxylic acid6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acidCD 271CD-271
来自此来源的交叉引用

映射方: Exact CAS cross-reference in the ChEBI compound record. 来源更新: 2017-02-22. 检索时间: 2026-08-31. 打开来源记录

NIH PubChem PUG-View
标识符精确匹配60164

Attributed physical-property, hazard, environmental and use annotations.

  • Exposure Routes: Absorption of adapalene through human skin is low. Only trace amounts (<0.25 ng/mL) of parent substance have been found in the plasma of acne patients following chronic topical application of adapalene in controlled clinical trials 来源: Toxin and Toxin Target Database (T3DB)
  • Note: This chemical does not meet GHS hazard criteria for 9.1% (1 of 11) of reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Warning 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (18.2%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (72.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (54.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (72.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (18.2%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H361 (81.8%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 11 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 11 reports by companies.; There are 6 notifications provided by 10 of 11 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Toxicity Summary: If the adapalene is applied excessively, marked redness, scaling, or skin discomfort may occur. In addition, according to product labeling, chronic ingestion of the drug may lead to the same adverse drug reactions associated with excessive oral intake of vitamin A. 来源: StatPearls
  • Toxicity Summary: Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation. 来源: Toxin and Toxin Target Database (T3DB)
  • Uses: Use (kg) in USA (2002): 78; Consumption (g per capita) in the USA (2002): 0.000278; Calculated removal (%): 97.7 来源: NORMAN Suspect List Exchange
  • Uses: For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back. 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
EMBL-EBI ChEBI精确匹配2026-08-31
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

本站如何使用 CAS 106685-40-9

CAS 106685-40-9 是化学文摘社 (Chemical Abstracts Service) 的标识符,用于将本页对应到特定物质。在当前数据集中,有 0 条欧盟附件记录共用该标识符,可帮助您交叉核对同一物质是出现在一种还是多种监管情境中。

当供应商规格书、SDS 或原料档案给出 CAS 106685-40-9,而您需要在一处查看所有关联的附件 II–VI 记录时,请使用本页。上方的条目卡片是查看浓度限值、警示语、附件归属和产品类型条件的最快途径。